At a time when market power and tight oligopoly seem to be the rule in India's health care sector, the new drug pricing policy is a boon to the... ...
http://www.firstpost.com/business/how-new-drug-policy-impacts-pharma-and-consumers-791419.htmlAlthough global economic recovery still remains fragile and the road back to normalcy is a long and difficult one, the fortunes of India's... ...
http://www.thehindu.com/business/Industry/world-economy-in-a-tizzy-but-indian-pharma-flying-high/article4706605.eceArun Kumar, of Strides Arcolab, has sold Agila, his cash machine. He is now turning to the bio-similars market. "We've been able to squeeze the... ...
http://www.moneycontrol.com/news/features/strides-arcolab-shifts-gears-after-agila-sale_857494.html--(PR.com)-- When preventing, investigating and prosecuting drug abuse in Indian Country, the focus is too often on the user, and little thought is... ...
http://www.bizwireexpress.com/showstoryPRcom.php?storyid=312743Mining complex user data real-time can help companies capitalize on hitherto-untapped business opportunities It is no longer a hypothesis. The... ...
http://computer.financialexpress.com/features/1236-the-big-world-of-analytics